McKesson Corporation vs Trane Technologies plc — how do they compare? McKesson Corporation trades at $983.95 (market cap $112.15B), while Trane Technologies plc trades at $471.85 (market cap $105.17B). The key difference: McKesson Corporation and Trane Technologies plc are close in size by market cap, and Trane Technologies plc pays the higher dividend (0.88%). Which is the better fit depends on your goals.
| MCK | TT | |
|---|---|---|
Market Cap | $112.15B | $105.17B |
Volume | 743,618 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $995.69 | $503.46 |
52-Week Low | $725.17 | $376.43 |
Typical Hold Time | 74 Days | — |
Enterprise Value | $118.68B | $108.47B |
Dividend Yield | 0.39% | 0.88% |
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $976.57, up 2.18% with strong technical momentum and bullish analyst sentiment. The stock shows robust earnings performance with three consecutive quarterly beats and revenue growth from $309B to $359B annually. Recent news highlights the CVS Health partnership extension through 2032, reinforcing distribution stability. Technical indicators show bullish moving averages but overbought RSI levels near resistance at $978.
Outlook remains positive given earnings momentum and strategic partnerships, though valuation at 25.8x P/E and thin 1.12% net margins pose risks. Analysts maintain 80.65% buy ratings with $956 consensus target, slightly below current price. Key risks include drug pricing pressure and macroeconomic sensitivity. Institutional accumulation supports medium-term upside if execution continues.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →